A cluster-randomized study of clinician-patient shared vs standard reporting of symptomatic adverse events using PRO-CTCAE nested in a multicenter trial of multimodal therapy for rectal cancer (Alliance N1048 PROSPECT)
         Google Scholar   
Citation:
Qual Life Res vol 24 (Suppl 1) 1-191 (abstract 2)
Meeting Instance:
ISOQOL 2015
Year:
2015
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Volume 24, Issue 1 Supplement, October 2015
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
Health Outcomes    
Pharmas:
 
Grants:
HHSN261201000063C, U10CA180821, U10CA180882, 1UG1CA189823, CA077202, CA180888, CA180858, CA189820  
Corr. Author:
 
Authors:
                           
Networks:
LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, PA086, PCRC, SCOR   
Study
NCCTG-N1048
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2/3
Keywords: